Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Roquette, a pharmaceutical excipients producer, announced an agreement to acquire Qualicaps, a manufacturer of hard capsules for oral solid dosage.
read more
The generics drug market is projected to experience a 6.51% CAGR during between 2018 and 2028, according to a report from Research & Markets. The generics sector was valued at $416.06B last year, according to the report.
read more
Lupin Pharmaceuticals is voluntarily recalling two lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0.03mg/0.451 mg and Levomefolate Calcium Tablets 0.451 mg) to the patients, level due to out of specification (OOS) test results at the 12-month stability time point. Specifically, one lot (L200183) tested low for...
read more
CVC Technologies, a pharmaceutical packaging and processing equipment company, has acquired encapsulation specialist Changsung Softgel System.
read more
The liquid, powder, and specialty coating market is estimated to grow by $5.4B from 2022 to 2027 at a CAGR of 5.48%, according to a report by Technavio.
read more
Upsher-Smith Laboratories announced the recent launch of VIGADRONE® (vigabatrin) tablets, USP 500 mg. The medicine is a fully substitutable, AB-rated generic version of Sabril® (vigabatrin) Tablets, 500 mg.
read more
The B-7 (also known as biotin) supplement market was valued at $583.36M in 2021, and is estimated to reach $1.4B by 2031, growing at a CAGR of 9.1% from 2022 to 2031.
read more
The cannabidiol market is to grow by $23B from 2022 to 2027, progressing at a CAGR of 16.28% during the forecast period, according to a report from Technavio.
read more
The global sexual health supplements market is expected to reach a value of $4.201 billion by 2028 from $2.548 billion in 2022, growing at a CAGR of 8.69% from 2022-2028, according to a report by Research & Markets.
read more
The FDA issued a draft guidance to help applicants incorporate QTc interval prolongation-related information into the labeling of non-antiarrhythmic human prescription drug and biological products.
read more
Growing demand for nutraceutical products is pushing the growth of nutra packaging, with a projected market value of $4.2B by 2028, at a CAGR of 4.7%, according to a Markets And Markets report..
read more
The antithrombotic drugs market size is poised to grow by $23M from 2022 to 2027, according to a report by Technavio. The market's growth momentum will progress at a CAGR of 8.42%.
read more
The pharmaceutical packaging market size is expected to grow by $48,889.6M during 2022-2027, expanding at a CAGR of 8.44%, according to a report by Technavio.
read more
The US pet supplements market was valued at $890M in 2022 and is expected to reach
$1.38B by 2028, growing at a CAGR of 7.60% during the forecast period, according to a report from Research & Markets.
read more
The U.S. Food and Drug Administration (FDA) has approved INGREZZA® (valbenazine) capsules for the treatment of adults with chorea associated with Huntington's disease (HD).INGREZZA, by Neurocrine Biosciences, is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor.
read more